Pfizer’s RSV vaccine, Abrysvo, generated $515 million in revenue in 2023. Pharma giant Pfizer said on Tuesday that it plans to seek regulatory approval to expand the allowed use of its RSV vaccine, ...

Despite the Centers for Disease Control and Prevention's recommendations, vaccine rates against COVID-19, RSV, and the flu ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

Fall means it’s time for just about everybody to get up to date on their flu and COVID-19 vaccines – and a lot o ...

As fall gets underway, we look forward to cooler weather, back-to-school shopping, football kick-offs and the long-awaited ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

Get vaccinated now to protect against COVID-19, flu, and RSV this respiratory virus season, health officials recommend.

As many as 80,000 children under 5 are hospitalized each year due to the respiratory syncytial virus, according to the CDC.

Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people ...

Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people she said are most vulnerable to the disease.

A new study highlights risk factors for hospitalization and severe illness among adults with respiratory syncytial virus (RSV ...

With the start of fall, the threat of RSV increases. RSV is a common respiratory virus with cold-like symptoms that can be mild for most. However, it's particularly dangerous for babies, as it's the ...